Fuji Pharma Co Ltd (4554)

Currency in JPY
1,456.0
-14.0(-0.95%)
Delayed Data·

4554 Financial Summary

Key Ratios

P/E Ratio11.29
Price/Book0
Debt / Equity69.38%
Return on Equity6.78%
Dividend Yield3.10%
EBITDA7.56B
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2015
30/09
2016
30/09
2017
30/09
2018
30/09
2019
30/09
2020
30/09
2021
30/09
2022
30/09
2023
30/09
2024
30/09
* In Millions of JPY (except for per share items)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 125.81%
Dividend Yield
3.10%
Industry Median 2.53%
Annualised payout
45.50
Paid unevenly
5-Years Growth
+7.94%
Growth Streak

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 2,150.0
(+47.66% Upside)

Earnings

Latest Release
Aug 07, 2025
EPS / Forecast
22.24 / --
Revenue / Forecast
12.86B / 13.30B
EPS Revisions
Last 90 days

FAQ

What were Fuji Pharma Co Ltd's earnings for the latest quarter?

The Fuji Pharma Co Ltd EPS (TTM) is 125.81. Fuji Pharma Co Ltd reported sales of 12,859.00, net income of 543.00, and EPS of 22.24 for the latest quarter.

What was Fuji Pharma Co Ltd's net income for the latest quarter?

Fuji Pharma Co Ltd's net income for the latest quarter was 543.00.

How did Fuji Pharma Co Ltd's performance compare year-over-year in the latest quarter?

The company's revenue moved from 11,095.00 in the previous quarter to 12,859.00 in the latest quarter, and net income moved from 296.00 to 543.00 compared to the previous quarter.

What is Fuji Pharma Co Ltd's net profit margin on a TTM basis?

Fuji Pharma Co Ltd's trailing twelve months (TTM) net profit margin is 13.32%.

How does Fuji Pharma Co Ltd's debt to equity ratio compare to industry standards?

Fuji Pharma Co Ltd's total debt-to-equity ratio is 69.38%.

What is Fuji Pharma Co Ltd's return on investment on a TTM basis?

Fuji Pharma Co Ltd's trailing twelve months (TTM) return on investment (ROI) is 6.78%.

What were Fuji Pharma Co Ltd's total assets and liabilities in the latest quarter?

As of the latest quarter, Fuji Pharma Co Ltd reported total assets of 93,509.00 million and total liabilities of 31,898.00 million.

How has Fuji Pharma Co Ltd's total revenue grown this year?

Fuji Pharma Co Ltd's total revenue was 11,095.00 in the previous quarter and 12,859.00 in the latest quarter.

What is Fuji Pharma Co Ltd's gross margin on a TTM basis?

Fuji Pharma Co Ltd's trailing twelve months (TTM) gross margin is 40.22%.

What was Fuji Pharma Co Ltd's revenue per share for the latest quarter?

Fuji Pharma Co Ltd's revenue per share for the latest quarter was 1,948.93.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.